MyFinsight
Home
Compare
Blog
About
Back
Income Statement
Ernexa Therapeutics Inc. (ERNAW)
Ernexa Therapeutics Inc. (ERNAW)
source: myfinsight.com
Net loss
attributable to common...
-$4,017,000
Net loss
-$4,009,000
Series a preferred
stock dividend
$8,000
Interest income
(expense), net
$55,000
Gain on
extinguishment of contingent...
$41,000
Loss before income
taxes
-$4,009,000
Total other income
(expense), net
$95,000
Other expense, net
-$1,000
Loss from operations
-$4,104,000
Total operating
expenses
$4,104,000
Research and development
$2,792,000
General and
administrative
$1,312,000
Back